Cytoskeleton: Capturing intermediate filament networks

Mapping intermediate filaments in three dimensions reveals that the organization of these filaments differs across cell types.
  1. Pierre A Coulombe  Is a corresponding author
  1. Department of Cell and Developmental Biology, Department of Dermatology, and Rogel Cancer Center, University of Michigan Medical School, United States

Cells are highly structured systems that contain a network of filaments known as the cytoskeleton. This scaffolding structure helps cells to maintain their shape, internal organization, and integrity under stress. It also plays important roles in intracellular transport, cell signaling and in cell proliferation, growth, differentiation and death. To fulfill their purpose, cytoskeletal filaments must be spatially organized, regulated and integrated in a manner that meets the rapidly changing needs of a cell (Kim and Coulombe, 2007; Block et al., 2015).

Recent advances in microscopy and image analysis have provided transformative insight into the three-dimensional (3D) architecture of cellular components in tissues, organs and entire organisms. Now, in eLife, Rudolf Leube and colleagues at RWTH Aachen University – including Reinhard Windoffer as first author – report on new insights into networks of intermediate filaments in three different types of epithelial cells (Windoffer et al., 2022).

The researchers used confocal microscopy and newly developed image analysis tools to describe the 3D organization of the entire intermediate filament network in three types of epithelial cells: MDCK cells, which are derived from canine kidneys, HaCaT keratinocytes derived from human skin, and retinal pigment epithelial (RPE) cells from mice. To visualize the network of keratin intermediate filaments in all three cell types, a specific keratin, known as Keratin 8 (K8), was tagged with a green fluorescence marker. The 3D models were generated based on microscopy images of filaments containing fluorescent K8, and the digitized representations of these images were analyzed at different scales to quantitatively describe the properties of the filaments and the networks they form.

From a methodology standpoint alone, the study by Windoffer et al. breaks new ground and sets the stage for an atlas-type collection holding information on the organization and architecture of intermediate filaments for a plethora of cell types, under various biological conditions. Among the myriad findings reported in this article, three stand out because they help capture the breadth of the study.

First, on a cellular scale, intermediate filaments show a specific spatial organization in the three cell types analyzed. For instance, MDCK kidney cells feature distinct apical and basal keratin intermediate filament networks that are interconnected but each possess unique features (Figure 1). HaCat cells are comparatively very flat and are densely packed with keratin filaments that enclose the nucleus laterally and include long bundles that run parallel to the cell’s longest axis. Retinal pigment epithelial (RPE) cells, which were analyzed in the natural context of the eye in situ, exhibit a comparatively less dense keratin intermediate filament network that is surprisingly prominent in the cytoplasmic apical domain, which faces photoreceptor cells in the retina. The mechanisms underlying these differences, and others reported by the researchers, are certainly worth investigating.

Intermediate filaments in different cell types.

Top left: Lateral view of intermediate filament networks in canine kidney epithelial cells (MDCK). The connected apical and basal networks each possess unique features. Bottom left: Human skin keratinocytes (HaCaT) are flat and densely packed, with long bundles of intermediate filaments enclosing the nucleus laterally. Right: Retinal pigment epithelial cells (RPE) in the (mouse) eye in situ show a comparatively less dense network that is surprisingly prominent in the apical area, which faces photoreceptor cells in the retina.

Image credit: Images reproduced from Windoffer et al. with permission, CC BY 4.0 (Windoffer et al., 2022).

Second, at a subcellular level, Windoffer et al. provide a thorough account of several key properties of intermediate filaments, which help inform the reciprocal interplay between mechanical forces and network architecture at both local and cell-wide levels. Again, an interesting mix of convergence and divergence are reported for the three cell types analyzed.

Third, at a molecular level, conversions of digital representations of the intermediate filaments into biochemical quantities revealed that the mass of keratin in skin keratinocytes is similar to mass measurements obtained using quantitative western blotting (Feng et al., 2013). Such detailed knowledge can help guide future efforts to identify and characterize the mechanisms that regulate the amount of keratin proteins and filaments present in several types of epithelial cells.

With this rigorous, innovative and elegant study, Windoffer et al. provide a methodological framework to probe the architecture and organizing principles of intermediate filament networks for any cell type in 3D. This contribution is timely in that it complements emerging evidence about the high-resolution structure of mature, intermediate filaments emanating from cryo-electron tomography imaging (e.g., Turgay et al., 2017; Weber et al., 2021) and also from crystallographic studies (e.g., Lee et al., 2020; Eldirany et al., 2021).

High resolution information about both core architecture of individual intermediate filaments and their spatial organization as intricate 3D networks within cells is sorely needed to foster a deeper understanding of their mechanical and non-mechanical roles in epithelial cells, and their disruption in disease. As we await additional quantitative data of intermediate filaments networks in other cell types and/or biological circumstances, the study by Windoffer et al. sets the stage for follow-up analyzes regarding the principles and mechanisms underlying the spatial organization of intermediate filaments in vivo.

References

Article and author information

Author details

  1. Pierre A Coulombe

    Pierre A Coulombe is in the Department of Cell and Developmental Biology, Department of Dermatology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, United States

    For correspondence
    coulombe@med.umich.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0680-2373

Publication history

  1. Version of Record published: April 4, 2022 (version 1)

Copyright

© 2022, Coulombe

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,153
    views
  • 112
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Pierre A Coulombe
(2022)
Cytoskeleton: Capturing intermediate filament networks
eLife 11:e78248.
https://doi.org/10.7554/eLife.78248
  1. Further reading

Further reading

    1. Cell Biology
    Yuki Date, Yukiko Sasazawa ... Shinji Saiki
    Research Article Updated

    The autophagy-lysosome pathway plays an indispensable role in the protein quality control by degrading abnormal organelles and proteins including α-synuclein (αSyn) associated with the pathogenesis of Parkinson’s disease (PD). However, the activation of this pathway is mainly by targeting lysosomal enzymic activity. Here, we focused on the autophagosome-lysosome fusion process around the microtubule-organizing center (MTOC) regulated by lysosomal positioning. Through high-throughput chemical screening, we identified 6 out of 1200 clinically approved drugs enabling the lysosomes to accumulate around the MTOC with autophagy flux enhancement. We further demonstrated that these compounds induce the lysosomal clustering through a JIP4-TRPML1-dependent mechanism. Among them, the lysosomal-clustering compound albendazole promoted the autophagy-dependent degradation of Triton-X-insoluble, proteasome inhibitor-induced aggregates. In a cellular PD model, albendazole boosted insoluble αSyn degradation. Our results revealed that lysosomal clustering can facilitate the breakdown of protein aggregates, suggesting that lysosome-clustering compounds may offer a promising therapeutic strategy against neurodegenerative diseases characterized by the presence of aggregate-prone proteins.

    1. Cancer Biology
    2. Cell Biology
    Savvas Nikolaou, Amelie Juin ... Laura M Machesky
    Research Article Updated

    Pancreatic ductal adenocarcinoma carries a dismal prognosis, with high rates of metastasis and few treatment options. Hyperactivation of KRAS in almost all tumours drives RAC1 activation, conferring enhanced migratory and proliferative capacity as well as macropinocytosis. Macropinocytosis is well understood as a nutrient scavenging mechanism, but little is known about its functions in trafficking of signalling receptors. We find that CYRI-B is highly expressed in pancreatic tumours in a mouse model of KRAS and p53-driven pancreatic cancer. Deletion of Cyrib (the gene encoding CYRI-B protein) accelerates tumourigenesis, leading to enhanced ERK and JNK-induced proliferation in precancerous lesions, indicating a potential role as a buffer of RAC1 hyperactivation in early stages. However, as disease progresses, loss of CYRI-B inhibits metastasis. CYRI-B depleted tumour cells show reduced chemotactic responses to lysophosphatidic acid, a major driver of tumour spread, due to impaired macropinocytic uptake of the lysophosphatidic acid receptor 1. Overall, we implicate CYRI-B as a mediator of growth and signalling in pancreatic cancer, providing new insights into pathways controlling metastasis.